Literature DB >> 22948234

Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway.

Bo Li1, Yuehua Yang, Shengdan Jiang, Binbin Ni, Ke Chen, Leisheng Jiang.   

Abstract

Bone morphogenetic proteins (BMPs) are members of the TGF-β superfamily of signaling molecules and have previously been shown to be associated with the biological behavior of osteosarcoma. However, to date the effects and molecular mechanisms of BMP-9 on osteosarcoma progression are unknown. We performed real-time PCR and western blot analysis to characterize the endogenous expression of BMP-9 in osteosarcoma cell lines. We used a recombinant adenovirus expressing BMP-9 (adBMP-9) to infect osteosarcoma cell lines with relatively low endogenous BMP-9 expression to determine the functional relevance of BMP-9 overexpression to osteosarcoma cell growth and migration in vitro and in vivo, and further investigated the expression levels of Ki-67, matrix metallopeptidase-9 (MMP-9), phosphoinositide 3-kinase p85α (PI3Kp85α) and phosphorylated AKT (p-AKT). As a result, osteosarcoma cell proliferation and migration were significantly diminished by adBMP-9, indicated by MTT and wound-healing assays, and cell apoptosis was markedly induced, indicated by Hoechst 33342/PI assay and Annexin V-FITC apoptosis detection. When BMP-9 expression was enhanced, the expression of PI3Kp85α, p-AKT, Ki-67 and MMP-9 was downregulated in osteosarcoma cells. In addition, the tumor volumes in MG-63 and HOS subcutaneous nude mouse models treated with adBMP-9 were significantly smaller compared to those of the ad-GFP group. These results suggested that the enhanced expression of BMP-9 in osteosarcoma cells by adBMP-9 exerted inhibitory effects on growth and migration of osteosarcoma cells possibly via blockade of the PI3K/AKT signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948234     DOI: 10.3892/ijo.2012.1617

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  19 in total

1.  Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth.

Authors:  Yong Zhao; Mei-Juan Tu; Yi-Feng Yu; Wei-Peng Wang; Qiu-Xia Chen; Jing-Xin Qiu; Ai-Xi Yu; Ai-Ming Yu
Journal:  Biochem Pharmacol       Date:  2015-10-27       Impact factor: 5.858

2.  The expression and clinical significance of high mobility group nucleosome binding domain 5 in human osteosarcoma.

Authors:  Xuhui Zhou; Bo Yuan; Wen Yuan; Ce Wang; Rui Gao; Junyan Wang
Journal:  Tumour Biol       Date:  2014-04-02

3.  Ferulic acid inhibits proliferation and promotes apoptosis via blockage of PI3K/Akt pathway in osteosarcoma cell.

Authors:  Ting Wang; Xia Gong; Rong Jiang; Hongzhong Li; Weimin Du; Ge Kuang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  Tanshinone IIA Inhibits Osteosarcoma Growth through a Src Kinase-Dependent Mechanism.

Authors:  Chao Hu; Xiaobin Zhu; Taogen Zhang; Zhouming Deng; Yuanlong Xie; Feifei Yan; Lin Cai
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-30       Impact factor: 2.629

5.  BMP9 signaling in stem cell differentiation and osteogenesis.

Authors:  Joseph D Lamplot; Jiaqiang Qin; Guoxin Nan; Jinhua Wang; Xing Liu; Liangjun Yin; Justin Tomal; Ruidong Li; Wei Shui; Hongyu Zhang; Stephanie H Kim; Wenwen Zhang; Jiye Zhang; Yuhan Kong; Sahitya Denduluri; Mary Rose Rogers; Abdullah Pratt; Rex C Haydon; Hue H Luu; Jovito Angeles; Lewis L Shi; Tong-Chuan He
Journal:  Am J Stem Cells       Date:  2013-03-08

Review 6.  Roles of bone morphogenetic protein signaling in osteosarcoma.

Authors:  Alan Nguyen; Michelle A Scott; Sarah M Dry; Aaron W James
Journal:  Int Orthop       Date:  2014-09-11       Impact factor: 3.075

7.  BMP signaling in mesenchymal stem cell differentiation and bone formation.

Authors:  Maureen Beederman; Joseph D Lamplot; Guoxin Nan; Jinhua Wang; Xing Liu; Liangjun Yin; Ruidong Li; Wei Shui; Hongyu Zhang; Stephanie H Kim; Wenwen Zhang; Jiye Zhang; Yuhan Kong; Sahitya Denduluri; Mary Rose Rogers; Abdullah Pratt; Rex C Haydon; Hue H Luu; Jovito Angeles; Lewis L Shi; Tong-Chuan He
Journal:  J Biomed Sci Eng       Date:  2013-08

Review 8.  Bone morphogenetic protein signaling in musculoskeletal cancer.

Authors:  Myrto Bami; Andreas F Mavrogenis; Andrea Angelini; Mandy Milonaki; Evanthia Mitsiokapa; Dimitrios Stamoulis; Panayotis N Soucacos
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-04       Impact factor: 4.553

9.  Okadaic acid activates the PKR pathway and induces apoptosis through PKR stimulation in MG63 osteoblast-like cells.

Authors:  Tatsuji Haneji; Kanji Hirashima; Jumpei Teramachi; Hiroyuki Morimoto
Journal:  Int J Oncol       Date:  2013-04-17       Impact factor: 5.650

10.  Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells.

Authors:  Lei Wu; Liang Yang; Yu Xiong; Hua Guo; Xiaoli Shen; Zujue Cheng; Yan Zhang; Ziyun Gao; Xingen Zhu
Journal:  Tumour Biol       Date:  2014-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.